Pharmacokinetics, pharmacodynamics, and exposure–efficacy of dupilumab in adults with atopic dermatitis-Reference-Cited by-同舟云学术

Pharmacokinetics, pharmacodynamics, and exposure–efficacy of dupilumab in adults with atopic dermatitis

Published:2022-08-20 Issue:10 Volume:15 Page:2342-2354
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Kamal Mohamed A.¹,Davis John D.¹^ORCID,Kovalenko Pavel¹^ORCID,Srinivasan Kamal¹,Simpson Eric L.²^ORCID,Nakahara Takeshi³^ORCID,Sugaya Makoto⁴^ORCID,Igarashi Atsuyuki⁵,Ardeleanu Marius¹,Xu Christine⁶,Arima Kazuhiko⁷^ORCID

Affiliation:

1. Regeneron Pharmaceuticals, Inc. Tarrytown New York USA

2. Department of Dermatology Oregon Health & Science University Portland Oregon USA

3. Department of Dermatology Graduate School of Medical Sciences, Kyushu University Fukuoka Japan

4. Department of Dermatology International University of Health and Welfare Chiba Japan

5. Department of Dermatology NTT Medical Center Tokyo Japan

6. Sanofi Bridgewater New Jersey USA

7. Sanofi Tokyo Japan

Funder

Regeneron Pharmaceuticals, Inc.

Sanofi

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13363

Reference37 articles.

1. Atopic dermatitis

2. Investigating International Time Trends in the Incidence and Prevalence of Atopic Eczema 1990–2010: A Systematic Review of Epidemiological Studies

3. Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults

4. Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes

5. Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rademikibart (CBP‐201), a next‐generation monoclonal antibody targeting human IL‐4Rα: Two phase I randomized trials, in healthy individuals and patients with atopic dermatitis;Clinical and Translational Science;2023-10-17

2. The clinical relevance of dupilumab serum concentration in patients with atopic dermatitis: a two-center prospective cohort study;Journal of Dermatological Treatment;2023-05-02